Over the past century, this collective group of researchers has made numerous major breakthroughs in the field of equine health. Consider just some of these landmark contributions:
- 1930 - Work by researchers in the field of mare fertility related to breeding hygiene
resulted in an increase in pregnancy rates from 40-65 percent to 75-85 percent over
a five-year period.
- 1939 - The department was designated the National Salmonella Typing Center after
becoming internationally renowned for its work in that field.
- 1947-48 - Streptococcus /zooepidemicus was identified as the most frequent bacterial
cause of equine abortion and foal death.
- 1950s - Researchers devised much needed laboratory procedures for the study of equine
abortion virus (equine herpesvirus-1) infections, including development of the first
vaccine against this disease.
- 1950s - Equine viral arteritis (EVA) was defined for the first time as a specific
- 1954 – Gluck researchers were the first to discover and report acquired resistance
of Haemonchus contortus to phenothiazine in sheep. This is believed to be the first
record of a parasitic species in either humans or animals developing resistance
to a drug.
- 1960s - Development of the first multivalent vaccine against equine influenza, a
viral respiratory disease which affects a large percentage of the horse population
- 1966 - Research began on the mare’s response to extended (artificial) light in controlling
her reproductive cycle. This discovery changed forever the struggle to get mares
in foal earlier in the year.
- 1969 - Vaccine for Streptococcus equi (strangles) was developed and became commercially
- 1984- An epidemic of equine viral arteritis (EVA) enabled researchers for the first
time to confirm existence of the "carrier" state in stallions. This knowledge has
been pivotal in devising effective strategies for controlling the spread of EVA.
- 1993 - The Maxwell H. Gluck Equine Research Center was designated by the Office
International des Epizooties (World Organization for Animal Health) as a World Reference
Center for three significant equine viral diseases:
- Equine rhinopneumonitis
- Equine influenza
- Equine viral arteritis
- 1994 – Development of the first test for the diagnosis of horses affected with equine
protozoal myeloencephalitis (EPM), a parasitic neurological disease occurring in
horses in the Western Hemisphere.
- 1999 - Involvement of Gluck Center researchers in the development of Flu-Avert™,
a highly successful intranasal vaccine for equine subtype 2 influenza virus. The
modified-live virus vaccine was licensed by the USDA in 1999. In addition, work
on maternal influenza and equine herpesvirus 1 antibody interference by researchers
in the department led to new recommendations for foal vaccination protocols by the
American Association of Equine Practitioners.
- 2001 - Further research into EPM spawned the development of the first FDA-approved
medication available for treating the disease.
- 2001 - A group of Gluck Center scientists, in collaboration with other UK College
of Agriculture researchers, helped determine the cause of the early fetal losses,
late-term abortions and other problems that occurred in association with Mare Reproductive
Loss Syndrome (MRLS).
- 2005 –Gluck Center researcher initiates and is the first author of a "white paper"
that leads to full genome sequencing of the horse by the National Human Genome Research